Fundación Eduardo Anitua Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2011
NCT01465399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fundación Eduardo Anitua

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4